Research

Our competitive edge is created by deep insight into the industries in which we operate and our knowledge of the trends and activities that affect our clients. In our chosen sectors, we regularly publish reviews of the dynamics and strategic initiatives driving M&A activity, private equity investment and debt capital deployment.

For more information on our research output, please contact Keith Pickering on    +44 (0)20 7246 0500 or keithpickering@catalystcf.co.uk

View all or

 

research cover Comment & Opinion - Will there be a Brexit boom?

The UK’s decision to leave the EU represents a major opportunity for the country’s dynamic and world-leading pharmaceutical sector – despite warnings that Brexit could prompt pharma companies to quit the UK.

research cover Catalyst Pharma Fast 50

The inaugural Catalyst Pharma Fast 50, our list of the 50 fastest-growing privately owned pharmaceutical companies in the UK in 2016

PDF Catalyst Pharma Fast 50.pdf
Adobe Acrobat file - 3.4 mb
research cover UK Mental Health M&A 2014-2015 snapshot

The emergence of US trade buyers has energised the exit environment for owner managers and investors. We expect further consolidation over the next few years.

PDF UK Mental Health M&A 2014-2015 snapshot.pdf
Adobe Acrobat file - 0.7 mb
research cover Healthcare Sector M&A Update - Winter 2015/16

The past twelve months have seen a continuation of strong overall healthcare activity. Deal volumes across each sector have risen with pharmaceuticals recording a significant increase.

research cover Healthcare M&A 2015 snapshot

2015 saw a number of noticeable trends: pharma M&A and cross-border deals have grown significantly, and valuations continue to be strong for good businesses.

PDF Healthcare M&A 2015 snapshot.pdf
Adobe Acrobat file - 2.7 mb
Next page >
 

Catalyst advises PCMS Group on its sale to a management buy-out team backed by Inflexion Private Equity

Catalyst has advised PCMS Group, a leading provider of point-of-sale software and services for major retailers, on its sale to a management buy-out team, backed by Inflexion.  

Catalyst advises Caledonia Investments plc on the sale of The Sloane Club

Catalyst has advised Caledonia Investments plc on the sale of The Sloane Club, the private members club located in the heart of Chelsea, London. 

Advisor to Mahindra Comviva on its acquisition of Emagine International

We advised Mahindra Comviva on its acquisition of Emagine International, a leading provider of real-time contextual marketing software.  

Catalyst advises Graphite Capital on £72m buy-out of YSC Consulting

Catalyst, the UK business of Alantra, has advised Graphite Capital on the £72m management buy-out of YSC Consulting. 

Catalyst advises Birmingham-headquartered ITG on its sale to Equistone

Catalyst, the UK business of Alantra, has advised Inspired Thinking Group on its sale to Equistone Partners.